| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $543.7M | +7.4% |
| Cost of Revenue | $247.7M | +3.4% |
| Gross Profit | $295.9M | +11.1% |
| R&D Expense | $138.0M | -9.3% |
| SG&A Expense | $113.4M | -2.3% |
| Operating Income | -$167.9M | +15.2% |
| Interest Expense | $2.3M | -43.2% |
| Pre-tax Income | -$155.5M | -16.6% |
| Income Tax | $2.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $286.2M | +165.2% |
| Short-term Investments | $9.7M | -95.5% |
| Accounts Receivable | $116.0M | -3.7% |
| Current Assets | $440.2M | -5.1% |
| Total Assets | $1.45B | -4.8% |
| Current Liabilities | $104.5M | -29.3% |
| Long-term Debt | $337.6M | -1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.4M | +4432.0% |
| Capital Expenditures | $10.3M | -5.9% |
| Investing Cash Flow | $178.9M | -39.3% |
| Financing Cash Flow | -$17.1M | +94.8% |
| Free Cash Flow | $6.1M | +157.2% |
| +1278.3% |
| Net Income | -$158.1M | -18.8% |
| EPS (Basic) | -$1.14 | -10.7% |
| EPS (Diluted) | -$1.14 | -10.7% |
| Total Liabilities |
| $486.1M |
| -10.9% |
| Stockholders' Equity | $965.3M | -1.5% |